| |
| |
|
| Insider
Information: |
Fuchs Henry J |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
222,228 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,063,061 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
222,228 |
|
|
| Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2020-07-20 |
4 |
AS |
$130.00 |
$16,430,570 |
D/D |
(126,389) |
102,995 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2020-07-20 |
4 |
OE |
$63.10 |
$8,337,656 |
D/D |
126,389 |
229,384 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
87,537 |
160,383 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2007-12-04 |
4 |
S |
$10.78 |
$895,794 |
D/D |
(83,107) |
0 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2007-12-04 |
4 |
OE |
$2.76 |
$221,374 |
D/D |
80,208 |
83,107 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
68,052 |
212,146 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2016-02-29 |
4 |
D |
$81.87 |
$4,622,708 |
D/D |
(56,464) |
103,919 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
53,204 |
247,458 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2015-03-16 |
4 |
AS |
$123.57 |
$5,105,166 |
D/D |
(41,315) |
88,635 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2015-03-16 |
4 |
OE |
$21.51 |
$860,400 |
D/D |
40,000 |
129,950 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
38,790 |
158,113 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2023-03-16 |
4 |
D |
$93.41 |
$3,362,760 |
D/D |
(36,000) |
188,187 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2024-03-05 |
4 |
S |
$85.18 |
$3,010,396 |
D/D |
(35,341) |
212,117 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2024-03-15 |
4 |
D |
$83.87 |
$2,808,387 |
D/D |
(33,485) |
196,872 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
31,500 |
73,850 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-06-14 |
4 |
OE |
$21.51 |
$1,067,380 |
D/D |
31,000 |
175,848 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-06-14 |
4 |
AS |
$90.00 |
$2,790,085 |
D/D |
(31,000) |
155,167 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-02-22 |
4 |
OE |
$27.75 |
$853,192 |
D/D |
26,479 |
32,811 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-02-22 |
4 |
S |
$81.70 |
$2,168,403 |
D/D |
(26,479) |
6,332 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2008-05-16 |
4 |
AS |
$35.80 |
$936,311 |
D/D |
(26,041) |
16,975 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2007-08-30 |
4 |
S |
$38.19 |
$956,260 |
D/D |
(25,000) |
17,292 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2007-08-30 |
4 |
OE |
$21.01 |
$525,250 |
D/D |
25,000 |
42,292 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2008-05-16 |
4 |
OE |
$21.01 |
$525,250 |
D/D |
25,000 |
41,975 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2008-05-29 |
4 |
S |
$35.90 |
$897,663 |
D/D |
(25,000) |
16,975 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2008-05-29 |
4 |
OE |
$21.01 |
$525,250 |
D/D |
25,000 |
41,975 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
